🔗 Share this article

Given that the US continues making historic adjustments to its immunization schedules, an unexpected name appears unexpectedly: Dr. Tracy Beth Høeg, a US-based sports medicine doctor and epidemiologist who rose to prominence by casting doubt on Covid shots in the global health crisis and has concentrated on potential fatalities following COVID-19 vaccination in her recent time at the Food and Drug Administration.

Scheduled Changes to Pediatric Immunization Schedule

Health officials were set to announce major changes to the childhood vaccine schedule in December, synchronizing the US with Denmark’s national calendar, according to reports – a major change that would place the US out of step with a large portion of the international standard with no evidence for benefit. The announcement has been postponed until the new year.

In place of Vinay Prasad, Høeg is scheduled to present at the event. She was recently named acting director of the FDA’s CDER, the fifth person to lead the center this calendar year.

Consolidating Power at the Agency

The acting appointment could signify a closer partnership between the drug and vaccine divisions as Høeg and Dr. Prasad consolidate power at the agency – and it signals a greater focus upon rolling back already-approved vaccines at the FDA.

Dr. Høeg has often pushed for ending some childhood shot schedules in the US to become more similar to Denmark's approach, a country with universal health coverage and a number of inhabitants roughly the size of the state of Wisconsin.

So far statements, she has continued to focus on immunizations – usually the purview of Dr. Prasad, head of the FDA’s vaccine center – instead of pharmaceutical oversight.

Questions Over Qualifications

Dr. Høeg has no apparent experience in drug development, oversight or management, which has been standard for former directors of the Center for Biologics Evaluation and Research. She has been employed at the FDA as a top consultant to the FDA chief and CBER since March.

“It seems she lacks to have the necessary background” for running the drug-regulation department, said Dr. Jonathan Howard. “She lacks experience running a scientific study. She has no expertise in running a major agency. She lacks background in drug approvals.”

Former directors of the center would “grasp legal statutes and the science of pharmaceutical innovation”, commented Dr. Janet Woodcock. “Frankly, she doesn’t have the sort of resume that prior appointees who headed CBER have had.”

The drug center has an immense workload at the FDA, she pointed out.

“Many people just pays attention on the new drug program, but the off-patent medication office authorizes numerous off-brand pharmaceuticals. There is also a biologic copycat branch, OTC medication office and more, and every single one have to be managed,” Dr. Woodcock noted. “The responsibility you overlook, that’s the thing that I always told people is going to come back to haunt you.”

Additionally, a significant leadership component to the role, which oversees over 5,000 personnel. “It is a huge leadership role, if you execute it properly,” she said.

Agency Reaction and Controversial Policies

Regarding questions about Høeg’s qualifications and whether this assignment represents greater collaboration among FDA leaders on vaccines, a press secretary stated that the “inquiries are based on incorrect premises”.

“This background is consistent with the responsibilities of her job,” the representative explained, pointing to the time Dr. Høeg spent advising the agency head on “drug safety and approval science, including computerized risk analysis and shot safety tracking”.

In her interim role, Høeg takes over the agency head's controversial fast-track approval initiative, a controversial expedited medication authorization process that reportedly concerned her preceding directors. “By what process are these drugs being chosen for this fast-track system? Who makes the decisions?” Dr. Howard asked. “There is a lot of confidentiality happening at the regulatory body right now.”

In general, he stated, “the Food and Drug Administration appears to be shifting towards less stringent rules of pharmaceuticals, aside from shots.”

Public History on Vaccines

With vaccines, Høeg has a more documented, if troubling, history, Howard have noted. She released a study using unconfirmed public submissions to determine the rate of myocarditis following COVID-19 immunization. She advised the Florida top health official Dr. Joseph Ladapo, who allegedly have changed statistics to imply Covid vaccinations are pose a greater threat than they are.

Included in her “policy goals” for the current federal leadership featured changing regulations for recently developed shots and halting “unnecessary” vaccines, she stated post-election on a online show. At the FDA, Dr. Høeg has according to sources suggested barring adolescent males from obtaining Covid vaccinations.

“She’s an thorough ideologue who commences with her conclusions and tailors the evidence to accommodate the science in a extremely deceptive, dishonest way,” Dr. Howard said.

Taking Control and a “Campaign of Retribution”

Høeg aligned with other dissenters, {like|